Followers | 79 |
Posts | 24,558 |
Boards Moderated | 1 |
Alias Born | 09/08/2000 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LICY - .4011 Pre-market at .54/.543
Li-Cycle Announces $75 Million Strategic Investment from Glencore
RGLS - 1.38 Pre-market at 2.18/2.19
Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
ATNF - 3.53 Pre-market at 4.10/4.21
SONN - 1.85 Pre-market at 2.32/2.35
Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
LXRX - 2.17 Pre-market at 2.36/2.38
Lexicon shares are trading higher after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
MESO - 2.15 Pre-market at 2.62/2.63
Mesoblast Says FDA Supports Accelerated Approval Pathway for Heart Failure Treatment
AUUD - 3.07 Pre-market at 4.01/4.04
TCBP - 1.06 Pre-market at 2.05/2.06
https://stockcharts.com/sc3/ui/?s=TCBP
SOUN - 5.63 Pre-market at 6.06/6.07
AIRE - 1.25 Pre-market at 1.52/1.53
AIMD - 1.12 Pre-market at 2.50/2.51
PBM - 1.27 Pre-market at 3.10/3.11
Psyence Biomedical’s Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
MNMD - 5.94 Pre-market at 7.30/7.31
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
NKGN - 1.83 Pre-market at 2.25/2.27
LYT 2.31 Pre-market at 7.22/7.28
Lytus Technologies shares are trading higher after the company announced the launch of Lytus Cloud.
IMRN - 1.65 Pre-market at 3.35/3.40
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
IPA - 1.58 Pre-market at 2.26/2.27
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
BENF - .10 Pre-market at .1625/.1629
Beneficient Agrees To The Financing Of Liquidity Transactions For Three Separate Funds Managed By ff Venture Capital
BREA - 1.02 Pre-market at 2.37/2.38
Brera Holdings shares are trading higher after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company.
PHGE - .2311 Pre-market at .87/.88
BiomX Enters Merger Agreement With Adaptive Phage Therapeutics n Stock-For-Stock Transaction And Concurrent $50 Million Private Placement Financing; Former Stockholders Of BiomX Will Own Approximately 55% And The Former Stockholders Of APT Will Own Approximately 45% Of The Consolidated Entity
TPST - 3.17 Pre-market at 3.32/3.38
Tempest Announces Upcoming Presentation Of Preclinical Data For TPST-1120 In Renal Cell Carcinoma At AACR Annual Meeting
LLAP - 1.17 Pre-market at 1.27/1.28
Terran Orbital Awarded Up To $45M IDIQ By NASA To Support Space Technology Advancement
OCEA - 5.26 Pre-market at 6.02/6.09
SOUN - 4.96 Pre-market at 5.16/5.17
CELZ - 4.129 Pre-market at 5.70/5.86
Creative Medical Technology Receives FDA Orphan Drug Designation For CELZ-101 In Key Transplantation Therapy
MRAI - 1.53 Pre-market at 1.72/1.73
AISP - 4.95 Pre-market at 7.52/7.54
AISP - 1.65 Pre-market at 2.44/2.46
Airship AI Announces Significant Sole-Source Contract Award within the Department of Justice for Acropolis Enterprise Video and Data Management Platform
MNTS - .78 Pre-market at .9122/.9179
Momentus Awarded NASA Contract to Provide Flight and Payload Integration Services
PHUN - 12.41 Pre-market at 16.56/16.57
What's Going On With Phunware Shares After Donald Trump Wins In Multiple Republican Caucuses?
LVTX - 3.03 Pre-market at 3.34/3.35
LAVA Therapeutics shares are trading higher after the company announced a $7 million payment because Pfizer achieved a clinical milestone for PF-08046052.
CASI - 5.085 Pre-market at 7.16/7.225
CASI Pharma Shares Soar After Positive Preliminary Trial Data for Cancer Immunotherapy
OCEA - 2.58 Up .59
BBAI - 4.41 Up .95
Social Buzz: Wallstreetbets Stocks Advance Premarket; BigBear.ai, Super Micro Computer Poised for Gains
HSDT - 5.96 Up 1.40
Helius Medical Technologies Announced It Secured HCPCS Codes for Portable Neuromodulation Stimulator Mouthpiece And Controller
PHUN - 11.94 Up 4.72
Phunware Expands Hospitality Portfolio Via A Multi-Year Partnership With Escapades Memphrémagog And PAL+
RNLX - 1.57 Pre-market at 1.58/1.59
Renalytix Earlier Announced It Has Received An Unsolicited Approach From A Large And Well-Capitalized Publicly Listed Strategic Diagnostics Company
QNRX - 5.46 Up 2.65
Quoin Pharmaceuticals shares are trading higher after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.
OT: Dr. this AM....getting a later start.
ENVB - 1.45 Pre-market at 1.55/1.56
Enveric Biosciences shares are trading higher after the company announced it signed three non-binding term sheets to pursue the out-licensing of three classes of compounds.